SEVERANCE AGREEMENT FOR MARIA L. WEBBSeverance Agreement • May 10th, 2007 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research • New Jersey
This SEVERANCE AGREEMENT (the “Agreement”) is made and entered into as of the 10th day of May, 2007, by and between PHARMACOPEIA, INC., a Delaware corporation (hereinafter, the “Company”), and Maria L. Webb, Ph.D., an individual (hereinafter, “Employee”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 10th, 2007 • Pharmacopeia Drug Discovery Inc • Services-commercial physical & biological research • Delaware
the Exchange Act) not then beneficially owning more than fifty percent (50%) of the voting power of the outstanding securities of the Company or any of its controlling Affiliates acquires or otherwise becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of securities of the Company or any of its controlling Affiliates representing more than fifty percent (50%) of the voting power of the then outstanding securities of the Company with respect to the election of directors of the Company; (b) the Company (i) consummates a merger, consolidation or similar transaction with another Person where the voting securities of the Company or any of its controlling Affiliates outstanding immediately preceding such transaction (or the voting securities issued with respect to the voting securities of the Company or any of its controlling Affiliates outstanding immediately preceding such transaction) represent less than fifty percent (50%) of the voting powe
